These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 19186005)
41. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features. Boland JM; Colby TV; Folpe AL Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273 [TBL] [Abstract][Full Text] [Related]
42. Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours. Liau JY; Lee JC; Wu CT; Kuo KT; Huang HY; Liang CW Histopathology; 2013 Apr; 62(5):702-10. PubMed ID: 23425231 [TBL] [Abstract][Full Text] [Related]
43. MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action. Somaiah N; Tap W Cancer Treat Rev; 2024 Jan; 122():102668. PubMed ID: 38104352 [TBL] [Abstract][Full Text] [Related]
44. [Detection of methylation status of p16 tumor suppressor gene in soft tissue leiomyosarcoma]. Xu J; Yang G; Bu H; Guo L; Zhang S; Liu J Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):16-8. PubMed ID: 11866950 [TBL] [Abstract][Full Text] [Related]
45. Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma. Asano N; Yoshida A; Mitani S; Kobayashi E; Shiotani B; Komiyama M; Fujimoto H; Chuman H; Morioka H; Matsumoto M; Nakamura M; Kubo T; Kato M; Kohno T; Kawai A; Kondo T; Ichikawa H Oncotarget; 2017 Feb; 8(8):12941-12952. PubMed ID: 28099935 [TBL] [Abstract][Full Text] [Related]
46. Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms. Kyriazoglou A; Pagkali A; Kotsantis I; Economopoulou P; Kyrkasiadou M; Moutafi M; Gavrielatou N; Anastasiou M; Boulouta A; Pantazopoulos A; Giannakakou M; Digklia A; Psyrri A Cancer Treat Rev; 2024 Apr; 125():102716. PubMed ID: 38492514 [TBL] [Abstract][Full Text] [Related]
47. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type. Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655 [TBL] [Abstract][Full Text] [Related]
48. DNA hypermethylation status of multiple genes in soft tissue sarcomas. Kawaguchi K; Oda Y; Saito T; Yamamoto H; Takahira T; Kobayashi C; Tamiya S; Tateishi N; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2006 Jan; 19(1):106-14. PubMed ID: 16258501 [TBL] [Abstract][Full Text] [Related]
49. Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features. Makise N; Yoshida A; Komiyama M; Nakatani F; Yonemori K; Kawai A; Fukayama M; Hiraoka N Am J Surg Pathol; 2017 Nov; 41(11):1523-1531. PubMed ID: 28719466 [TBL] [Abstract][Full Text] [Related]
50. Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology. Kim YJ; Kim M; Park HK; Yu DB; Jung K; Song K; Choi YL Lab Invest; 2019 Sep; 99(9):1309-1320. PubMed ID: 31160689 [TBL] [Abstract][Full Text] [Related]
51. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease. García JF; Villuendas R; Algara P; Sáez AI; Sánchez-Verde L; Martínez-Montero JC; Martínez P; Piris MA Lab Invest; 1999 Dec; 79(12):1453-9. PubMed ID: 10616196 [TBL] [Abstract][Full Text] [Related]
52. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
53. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748 [TBL] [Abstract][Full Text] [Related]
54. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer. Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358 [TBL] [Abstract][Full Text] [Related]
55. Alterations of the RB1 gene in dedifferentiated liposarcoma. Takahira T; Oda Y; Tamiya S; Yamamoto H; Kobayashi C; Izumi T; Ito K; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2005 Nov; 18(11):1461-70. PubMed ID: 15933756 [TBL] [Abstract][Full Text] [Related]
56. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628 [TBL] [Abstract][Full Text] [Related]
57. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. Alves MK; Lima VP; Ferrasi AC; Rodrigues MA; De Moura Campos Pardini MI; Rabenhorst SH APMIS; 2010 Apr; 118(4):297-307. PubMed ID: 20402675 [TBL] [Abstract][Full Text] [Related]
58. Liposarcoma of the pleural cavity. Kawai T; Nakashima H; Washimi K; Yokose T; Matsuo T; Nakayama M; Shinohara N; Kuroda H; Ishida K; Akiba J; Ishikawa M; Urabe S; Shiraishi J; Shiraishi T; Sakamoto A; Matsukuma S Hum Pathol; 2023 Jun; 136():105-113. PubMed ID: 37023867 [TBL] [Abstract][Full Text] [Related]
59. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma. Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Iwamoto Y; Tsuneyoshi M Cancer Sci; 2004 Aug; 95(8):651-5. PubMed ID: 15298727 [TBL] [Abstract][Full Text] [Related]
60. Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient. Kukull BJ; Khalighi MA; Gundle KR; Hansford BG; Corless CL; Davis JL Pediatr Dev Pathol; 2020; 23(3):240-246. PubMed ID: 31739757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]